Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets:
Cash and cash equivalents	$ 278,620	$ 367,577
Restricted cash	6,089	21,498
Accounts receivable, net	29,252	40,549
Other receivable		28,000
Materials and supplies	43,933	40,429
Deferred costs, current	16,961	482
Prepaid expenses and other current assets	15,732	8,667
Total current assets	390,587	507,202
Property and equipment, net	1,842,549	1,915,172
Receivable from unconsolidated subsidiaries		204,790
Intangible asset		85,053
Investment in unconsolidated subsidiaries		11,876
Other assets	23,423	24,120
Total assets	2,256,559	2,748,213
Liabilities and shareholders' equity:
Accounts payable	24,223	14,941
Accrued expenses	27,924	25,744
Accrued interest	15,703	16,576
Deferred revenue, current	7,567
Total current liabilities	75,417	57,261
Long-term debt	1,073,734	1,039,335
Payable to unconsolidated subsidiaries		4,400
Other long-term liabilities	38,577	28,259
Total long-term liabilities	1,112,311	1,071,994
Total liabilities	1,187,728	1,129,255
Commitments and contingencies
Shareholders' equity:
Common shares, $0.01 par value per share, 82,500 shares authorized and issued and 75,007 and 75,031 shares outstanding as of December 31, 2019 and December 31, 2018, respectively	751	750
Additional paid-in capital	1,652,681	1,645,692
Treasury shares, at cost	(652)
Accumulated deficit	(583,949)	(27,484)
Total shareholders' equity	1,068,831	1,618,958
Total liabilities and shareholders' equity	$ 2,256,559	$ 2,748,213